M-Vac™

Investigated by: Department of State for Health and Social Welfare, The Gambia · GlaxoSmithKline · London School of Hygiene and Tropical Medicine · Medical Research Council Unit, The Gambia · PATH

today NCT01262872 · Ph 2

20112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT01262872	Feb 2011 → Mar 2013	streptococcal infection	GlaxoSmithKline	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	M-Vac	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01262872 ↗
Modality	Vaccine	“M-Vac™, Stamaril™ and Polio Sabin™ vaccines” NCT01262872 ↗